AQUMON has successfully developed and launched a Robo Advisor for CMB Wing Lung Bank in Early February 2021, after the first phase of the project became public in 2019. 

 

Hong Kong, Feb 2021- Amid the challenges brought by the pandemic, AQUMON is accelerating digitalization in the wealth management industry through its partnership with CMB Wing Lung Bank. Wealth-Tech, developed by AQUMON, is a Robo Advisory platform for CMB Wing Lung Bank that brings its clients a sophisticated, low-cost, and transparent investment option.

 

Increasing Adoption of Robo Advisory Technology

 

More banks are adopting Robo Advisory technology to save labour costs and expand on offerings. AQUMON partners with large financial institutions such as CMB Wing Lung Bank which have the customer reach and resources to lead this industry transformation. The investment market shows massive growth potential that is quickly being realised as investors worldwide become increasingly attuned to digital investment platforms and their benefits. 

 

Kelvin Lei, CEO & Co-Founder of AQUMON comments, “The pandemic has accelerated digitalization in the wealth management industry. Traditionally, clients would visit banks to manage their wealth in person. Now, scientific, automated and transparent investment methods are offered to clients; thus saving time and increasing efficiency. CMB Wing Lung Bank’s Wealth-Tech, the Robo Advisory platform developed by AQUMON, utilizes algorithms and scalable IT solutions to provide clients with a personalized investment solution. Throughout the partnership, CMB Wing Lung Bank has demonstrated its outstanding values and its commitment to digital transformation. AQUMON appreciates and holds the opportunity to partner with CMB Wing Lung Bank in high regard.” 

 

Simple, Automated Financial Solutions - AQUMON Bridges The Gap Between Complex Financial Operations and User Experience

 

CMB Wing Lung Bank’s Wealth-Tech is one of the first retail bank-based Robo Advisory offerings that provides investors with an automated, personalized mutual fund portfolio solution.  

 

Wealth-Tech is embedded in CMB Wing Lung Bank’s mobile app. Clients will undergo risk and investment preference assessments to ascertain their risk profile. A tailor-made portfolio is then recommended according to the clients’ risk appetite, region and sector preference. Following their purchase, monthly reports are provided to allow the client to review their portfolio’s performance. Portfolio rebalancing and redemption options are provided to ensure that the client’s investing preferences or needs are constantly reflected.

 

As the leader in quantitative strategies, AQUMON provides the core algorithm for CMB Wing Lung Bank's Robo Advisor. Utilizing AQUMON Multi-factor Fund selection module, Wealth-Tech systematically selects superior mutual funds as building blocks for client’s portfolios. The strategy analyzes factors such as AUM change, expense ratios, macroeconomic sensitivities, downside risk metrics, and track records. The portfolio optimization process is based on the Nobel Prize winning Mean-Variance Theorem and combines various extensions, such as the use of Black-Litterman to better estimate expected returns. Investment is made easy with a data-driven, rule-based platform that minimizes the influence of human judgement. 

 

Asia’s Growing Appetite for Digital Wealth Management Solutions

 

The APAC asset and wealth management industry is expected to be the focal point for global AUM growth, where the AUM is expected to grow faster than any other region globally 

with a 49% expected rise in AUM between 2017 and 2025*. Asia’s advantageous fintech regulatory environment will foster the growth of personalized wealth management solutions.

 

*Source: PwC Report 

 

As compared to its US counterparts, Robo Advisers in China are relatively new. However, China’s pilot launch of its Mutual Fund Advisory Scheme has eased regulatory restrictions and provided a more seamless customer experience for investors since 2019. Furthermore, at least 18 financial institutions have obtained mutual fund advisory licenses to serve their domestic investors^.

 

^Source: S&P Global Market Intelligence

 

AQUMON continues to fuel its ambition in expanding and making personalized wealth management more accessible in Greater China. Aside from the accomplishment of raising USD30m Series Pre-B financing and the plan to open an office in Shanghai this year, AQUMON has also obtained a Private Investment Fund License in Mainland China.

 

Kelvin Lei, CEO & Co-Founder of AQUMON comments, “This year, AQUMON plans to work with more financial institutions in providing Robo-Advisor as a Service (RaaS) and accelerating the implementation process. AQUMON also plans to expand its services and establish offices in Japan, Singapore, and Shanghai.”

For more information about the Wealth-Tech project, please contact:

 

Walter Huang, Institutional Client Group: walter.huang@magnumwm.com

 

 

 

 

 

About us

AQUMON is a Hong Kong based award-winning financial technology company. Our mission is to leverage smart technology to make next-generation investment services affordable, transparent and accessible to both institutional clients and the general public. Through its proprietary algorithms and scalable, technical infrastructure, AQUMON’s automated platform empowers anyone to invest and maximise their returns. AQUMON has partnered with more than 100 financial institutions in Hong Kong and beyond, including AIA, CMB Wing Lung Bank, ChinaAMC, and Guangzhou Rural Commercial Bank. Hong Kong University of Science and Technology, the Alibaba Entrepreneurs Fund, affiliate of BOC International Holdings Limited, Zheng He Capital Management and Cyberport are among AQUMON's investors. 

 

The brand is held under Magnum Research Limited and is licensed with Type 1, 4 and 9 under the Securities and Futures Commission (SFC) of Hong Kong. AQUMON is also licensed by the U.S. Securities and Exchange Commission (SEC) and the Asset Management Association of China (AMAC).

 

Disclaimer

Viewers should note that the views and opinions expressed in this material do not necessarily represent those of Magnum Research Group and its founders and employees. Magnum Research Group does not provide any representation or warranty, whether express or implied in the material, in relation to the accuracy, completeness or reliability of the information contained herein nor is it intended to be a complete statement or summary of the financial markets or developments referred to in this material. This material is presented solely for informational and educational purposes and has not been prepared with regard to the specific investment objectives, financial situation or particular needs of any specific recipient. Viewers should not construe the contents of this material as legal, tax, accounting, regulatory or other specialist of technical advice or services or investment advice or a personal recommendation. It should not be regarded by viewers as a substitute for the exercise of their own judgement. Viewers should always seek expert advice to aid decision on whether or not to use the product presented in the marketing material. This material does not constitute a solicitation, offer, or invitation to any person to invest in the intellectual property products of Magnum Research Group, nor does it constitute a solicitation, offer, or invitation to any person who resides in the jurisdiction where the local securities law prohibits such offer. Investment involves risk. The value of investments and its returns may go up and down and cannot be guaranteed. Investors may not be able to recover the original investment amount. Changes in exchange rates may also result in an increase or decrease in the value of investments. Any investment performance information presented is for demonstration purposes only and is no indication of future returns. Any opinions expressed in this material may differ or be contrary to opinions expressed by other business areas or groups of Magnum Research Limited and has not been updated. Neither Magnum Research Limited nor any of its founders, directors, officers, employees or agents accepts any liability for any loss or damage arising out of the use of all or any part of this material or reliance upon any information contained herein.